Canadian cannabis removal business, MediPharm Labs Corp. has established they own been chosen by the Mount Sinai Hospital in new york to be involved in a trial that is clinical on developing a non-addictive cannabidiol (CBD) gelcap for the treatment opioid addiction.
MediPharm will produce the gelcap using a proprietary hemp-derived CBD formula from licensed cannabis that are jamaican, Timeless Herbal Care Inc.
Dr. Yasmin Hurd of Mount Sinai states they opted for MediPharm as a result of the grade of the company’s products and their expertise in where to buy cbd oil in columbus ohio pharmaceutical and medical research.
“We are exceptionally happy MediPharm laboratories has been selected to be engaged in this landmark, medical test to correctly measure the potential great things about CBD and therefore may cause crucial medical treatments for millions struggling with opioid use disorder,” says MediPharm CEO Patrick McCutcheon. Read more